9 completed, 3 not yet recruiting, 2 recruiting, 2 terminated. 13 Not applicable, 3 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 13 | Completed 7, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Galactose: new trials by email Literature Review of Galactose trials Research Report on Galactose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Galactose as a Substrate for Post-Exercise Skeletal Muscle Glycogen Repletion in Individuals With Type 1 Diabetes galactose - Type 1 Diabetes | Not applicable | Not yet recruiting | University of Aarhus | 16 | 2027-02-01 | 2026-08-19 |
| AVTX-801 D-galactose Supplementation in SLC35A2-CDG AVTX-801, Placebo - SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation | Phase 2 | Not yet recruiting | Eva Morava-Kozicz | 10 | 2027-01-01 | 2026-06-29 |
| Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801) AVTX-801, Placebo - PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation | Phase 2 | Not yet recruiting | Eva Morava-Kozicz | 8 | 2026-10-01 | 2026-03-16 |
| Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics galactose, fructose, Glucose Powder - Glucose | Not applicable | Recruiting | University of Bath | 25 | 2026-01-01 | 2026-07-08 |
| Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I Fructose, Fructose and galactose - Glycogen Storage Disease Type I | Not applicable | Recruiting | Insel Gruppe AG, University Hospital Bern | 20 | 2025-04-24 | 2026-05-12 |
| The GALAXY-1 Project Galactose, No intervention - Healthy | Not applicable | Unknown | University of Aarhus | 8 | 2024-02-12 | 2024-04-23 |
| Galactose Supplementation for the Treatment of MOGHE D-Galactose - Refractory Epilepsy, SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation | Not applicable | Unknown | Hospital Ruber Internacional | 8 | 2021-01-15 | 2021-04-06 |
| Galactose Mediated Glycogen Resynthesis Glucose alone, Galactose alone, Glucose and galactose - Exercise | Not applicable | Completed | University of Birmingham | 9 | 2019-07-01 | 2023-01-04 |
| Effect of Galactose Ingestion on Postprandial Lipemia Galactose, Glucose - Cardiovascular Risk Factor, Lipemia | Not applicable | Completed | University of Bath | 10 | 2018-02-01 | 2018-05-24 |
| sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis Fibroscan, Ultrasound, Galactose - Wilsons Disease | Not applicable | Completed | University of Aarhus | 33 | 2016-02-01 | 2022-11-02 |
| Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C Galactose, Gastroscopy, Liver biopsy - Hepatitis C | Completed | University of Aarhus | 71 | 2015-01-01 | 2020-04-07 | |
| Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation D-Galactose - Congenital Disorders of Glycosylation | Not applicable | Completed | Tulane University | 8 | 2014-07-01 | 2021-01-08 |
| Direct Peritoneal Resuscitation Plus Conventional Resuscitation Galactose, Standard Treatment - Hepatic Cancer | Phase 4 | Withdrawn | University of Louisville | 2012-09-01 | 2017-05-05 | |
| Direct Peritoneal Resuscitation Effects in the Damage Control Patient Galactose, Standard surgical methods - Traumatic Injury | Not applicable | Completed | University of Louisville | 7 | 2012-01-01 | 2021-06-16 |
| SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition sweet block, bitter block, umami-block - Disorder of Glucose Regulation | Not applicable | Completed | German Institute of Human Nutrition | 97 | 2011-12-01 | 2020-06-24 |
| Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome D-Galactose - Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome | Not applicable | Completed | Children's National Research Institute | 7 | 2009-10-01 | 2014-09-15 |
| Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Adalimumab, Lisinopril, losartan, and atorvastatin, galactose - Focal Segmental Glomerulosclerosis | Phase 2 | Completed | NYU Langone Health | 32 | 2008-12-01 | 2016-07-11 |
| Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 Galactose - Focal Segmental Glomerulosclerosis | Phase 1 | Withdrawn | Northwell Health | 2008-12-01 | 2015-09-07 | |
| Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor Galactose - Focal Segmental Glomerulosclerosis | Phase 1 | Terminated | Northwell Health | 15 | 2008-12-01 | 2015-09-10 |
| Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema Galactose, intravenous - Diabetic Macular Oedema | Not applicable | Terminated | Glostrup University Hospital, Copenhagen | 1 | 2007-01-01 | 2007-06-26 |
Glomerulosclerosis, Focal Segmental (4) · Liver Cirrhosis (2) · Motor Activity (2) · Congenital Disorders of Glycosylation (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Drug Resistant Epilepsy (1) · Glucose Metabolism Disorders (1) · Glycogen Storage Disease Type I (1) · Glycogen Storage Disease XIV (1) · Hepatitis C (1) · Hepatolenticular Degeneration (1) · Hyperlipidemias (1) · Hypovolemia (1) · Insulin Resistance (1)
University of Aarhus (4) · Eva Morava-Kozicz (2) · Northwell Health (2) · University of Bath (2) · University of Louisville (2) · Children's National Research Institute (1) · German Institute of Human Nutrition (1) · Glostrup University Hospital, Copenhagen (1) · Hospital Ruber Internacional (1) · Insel Gruppe AG, University Hospital Bern (1) · NYU Langone Health (1) · Tulane University (1) · University of Birmingham (1)
United States (8) · Denmark (5) · United Kingdom (3) · Canada (1) · Germany (1) · Spain (1) · Switzerland (1)
Eva Morava-Kozicz, MD, PhD (3) · Howard Trachtman, MD (3) · Jason Smith, MD (2) · Andreas FH Peiffer, Prof (1) · Angel Aledo-Serrano, MD, PhD (1) · Asha Moudgil, MD (1) · Debbie Gipson, MD (1) · Dorte Nellemann Thornit, MD (1) · Gareth Wallis, PhD (1) · Jennifer Gassman, PhD (1) · Kristen Sgambat, MS, RD (1) · Michel Hochuli, MD, PhD (1)
PMID 19073787, PMID 19932542, PMID 21310077, PMID 26198842, PMID 26721819, PMID 30241550, PMID 32297937, PMID 33743737, PMID 35224732, PMID 36857956, PMID 40337980
R33DK070341 (1), U54NS115198 (1)